MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202521062104 A) filed by Government College Of Engineering; Jiotode, Prathamesh P; Kuralkar, Arya A; Jadhao, Piyush S; Thakare, S S; Deshmukh, P R; Metkar, Rajesh; and Lohi, S. A., Amravati, Maharashtra, on June 30, for 'a medicine box for tuberculosis patients.'
Inventor(s) include Jiotode, Prathamesh P.; Kuralkar, Arya A.; Jadhao, Piyush S.; Thakare, S. S.; Deshmukh, P. R.; Metkar, Rajesh; and Lohi, S. A.
The application for the patent was published on Nov. 21, under issue no. 47/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a medicine box for tuberculosis patients. This medicine box integrates AI-based facial recognition to authenticate the patient, followed by motion detection to confirm tablet ingestion. A dual-stage alert mechanism includes a first alert activated at scheduled medicine times, and a second alert that continues until ingestion is verified. A central processor manages AI inference and sensor inputs, while a wireless communication module transmits real-time notifications to caregivers or healthcare professionals, including reminders, user authentication results, ingestion confirmation, and fault alerts. A dedicated risk alert generator continuously monitors system hardware and software, promptly reporting malfunctions. This IoT-enabled solution enhances treatment adherence, reduces risks of drug resistance and relapse, and supports remote healthcare monitoring. The system is suitable for use in TB treatment centers, home care, and public health programs, offering improved patient compliance and safety through multi-level automated monitoring."
Disclaimer: Curated by HT Syndication.
